Answers are grounded in this paper and cite their sources.
Systematic review evaluates manuka honey efficacy and safety for chronic rhinosinusitis, suggesting potential benefits.
Chronic rhinosinusitis (CRS) is a common, debilitating condition that often persists despite conventional treatments, compounded by increasing antibiotic resistance. Manuka honey (MH) has demonstrated potent antimicrobial and antibiofilm activity, making it a potential alternative or adjunctive therapy. This systematic review evaluated the efficacy and safety of MH for CRS management compared to standard care. Comprehensive searches of PubMed, Web of Science, and the Cochrane Library identified six studies (four randomized controlled trials, one cohort study, and one case report) published between 2011 and 2019, involving 226 patients. Some trials reported improvements in symptom scores such as Sino-Nasal Outcome Test-22, visual analog scale, and endoscopic scores with MH irrigation compared to saline or placebo. However, differences were not consistently statistically significant. One cohort study suggested anti-inflammatory effects, while others indicated potential benefits in allergic fungal rhinosinusitis. Across all studies, MH irrigation was well tolerated, with no serious adverse events reported. The evidence remains limited by small sample sizes, heterogeneity in outcome measures, and variations in MH formulations and administration protocols. According to recent research, MH irrigation is a biologically viable and typically safe supplement to CRS treatment. However, other trials reported more benefit in control groups, and improvements in symptom and endoscopic scores were moderate, variable, and sometimes not statistically significant. As a result, rather than altering practice, the data is still preliminary and just generates hypotheses. To elucidate the clinical effectiveness, best practice, and suitable patient selection for MH treatment, larger, methodologically sound randomized controlled studies are needed.
No takes yet. Share an insight, caveat, or question.
Aldahlawi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: